Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 10 is a processed pseudogene of UBE2V1—an enzyme involved in protein ubiquitination—but does not encode a functional protein product. Pseudogenes such as UBE2V1P10 are typically non-functional remnants of protein-coding genes and are not considered therapeutic targets or associated with disease mechanisms or drug interactions. Information about protein function, interactions, therapeutic relevance, or expression is not applicable, as this gene does not produce an active protein[5]. UBE2V1P10 is not a protein-coding gene; it is a pseudogene and thus not a traditional drug or therapeutic target[5]. No evidence links UBE2V1P10 to biological functions, disease roles, pharmacological targeting, or biomarker use. Its parent/related coding gene, UBE2V1, does play significant roles in cell signaling and ubiquitination pathways[1][3], but these functions do not apply to UBE2V1P10. If you are seeking information on the functional protein, refer instead to "Ubiquitin-conjugating enzyme E2 variant 1" (UBE2V1), not its pseudogene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2V1 pseudogene 10 (UBE2V1P10).